Patent details

Basic Information

Publication number:

EP2277543

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP100108844

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Therapeutic anti-IL-1R1 monoclonal antibody

French Title of Invention:

Anticorps monoclonal anti-IL-1R1 thérapeutique

German Title of Invention:

Therapeutischer monoklonaler Anti-IL-1R1-Antikörper

SPC Number:

Dates

Filing date:

05/09/2003

Grant date:

16/12/2015

EP Publication Date:

16/12/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/01/2011

EP B1 Publication Date:

16/12/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/09/2016

Expiration date:

05/09/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/09/2003

 

 

Name:

Amgen Inc

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Name:

E. R. Squibb & Sons L.L.C.

Address:

Route 206 & Province Line Road, Princeton, NJ 08540, United States (US)

Inventor

1

Name:

Vezina Chris

Address:

United States (US)

2

Name:

Qian Xueming

Address:

United States (US)

3

Name:

Elliott Gary

Address:

United States (US)

4

Name:

Witte Alison

Address:

United States (US)

5

Name:

Varnum Brian

Address:

United States (US)

6

Name:

Martin Frank

Address:

United States (US)

7

Name:

Huang Haichun

Address:

United States (US)

Priority

Priority Number:

408719 P

Priority Date:

06/09/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages